Smith & Nephew SNATS Net Income 2010-2024 | SNN

Smith & Nephew SNATS annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Smith & Nephew SNATS net income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS net income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS annual net income for 2024 was $0.412B, a 56.65% increase from 2023.
  • Smith & Nephew SNATS annual net income for 2023 was $0.263B, a 17.94% increase from 2022.
  • Smith & Nephew SNATS annual net income for 2022 was $0.223B, a 57.44% decline from 2021.
Smith & Nephew SNATS Annual Net Income
(Millions of US $)
2024 $412
2023 $263
2022 $223
2021 $524
2020 $448
2019 $600
2018 $663
2017 $767
2016 $784
2015 $410
2014 $501
2013 $556
2012 $729
2011 $582
2010 $615
2009 $472
Smith & Nephew SNATS Quarterly Net Income
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31 $160
2014-09-30 $102
2014-06-30 $89
2014-03-31 $150
2013-12-31 $162
2013-09-30 $122
2013-06-30 $129
2013-03-31 $143
2012-12-31 $142
2012-09-30 $134
2012-06-30 $292
2012-03-31 $161
2011-12-31 $140
2011-09-30 $133
2011-06-30 $153
2011-03-31 $156
2010-12-31 $182
2010-09-30 $137
2010-06-30 $137
2010-03-31 $159
2009-12-31 $128
2009-09-30 $128
2009-06-30 $118
2009-03-31 $98
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.157B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.711B 27.62
Boston Scientific (BSX) United States $154.351B 38.64
Stryker (SYK) United States $149.416B 31.24
EssilorLuxottica (ESLOY) France $132.057B 0.00
Medtronic (MDT) Ireland $115.083B 16.32
Lonza Group Ag (LZAGY) Switzerland $49.624B 0.00
Haleon (HLN) United Kingdom $44.474B 25.39
ResMed (RMD) United States $37.259B 27.99
Agilent Technologies (A) United States $34.110B 22.24
GE HealthCare Technologies (GEHC) United States $34.090B 16.18
Terumo (TRUMY) Japan $24.459B 31.77
Koninklijke Philips (PHG) Netherlands $23.149B 16.24
Insulet (PODD) United States $20.550B 80.67
Zimmer Biomet Holdings (ZBH) United States $18.570B 11.93
Baxter (BAX) United States $14.641B 10.93
Demant (WILYY) Denmark $8.633B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.825B 23.75
Lantheus Holdings (LNTH) United States $5.747B 14.50
Prestige Consumer Healthcare (PBH) United States $3.776B 16.87
Perrigo (PRGO) Ireland $3.768B 9.55
Haemonetics (HAE) United States $3.683B 16.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.395B 28.21
ICU Medical (ICUI) United States $3.220B 23.75
QuidelOrtho (QDEL) United States $1.952B 13.42
LeMaitre Vascular (LMAT) United States $1.900B 42.47
AtriCure (ATRC) United States $1.550B 0.00
Acuren (TIC) United States $1.455B 0.00
Green Thumb Industries (GTBIF) United States $1.374B 30.91
Phibro Animal Health (PAHC) United States $1.278B 16.34
AdaptHealth (AHCO) United States $1.237B 12.56
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.053B 0.00
InMode (INMD) Israel $0.932B 9.39
Kestra Medical Technologies (KMTS) United States $0.792B 0.00
Curaleaf Holdings (CURLF) Canada $0.749B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.680B 0.00
Tilray Brands (TLRY) Canada $0.661B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Evolus (EOLS) United States $0.613B 0.00
CeriBell (CBLL) United States $0.592B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.449B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.337B 0.00
VAREX IMAGING (VREX) United States $0.327B 12.02
Sanuwave Health (SNWV) United States $0.310B 0.00
Cresco Labs (CRLBF) United States $0.306B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.302B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Aurora Cannabis (ACB) Canada $0.257B 76.33
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.249B 11.30
Brainsway (BWAY) Israel $0.231B 61.17
Omeros (OMER) United States $0.230B 0.00
OraSure Technologies (OSUR) United States $0.230B 0.00
Verano Holdings (VRNOF) United States $0.226B 0.00
Biote (BTMD) United States $0.221B 6.22
Canopy Growth (CGC) Canada $0.215B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
High Tide (HITI) Canada $0.195B 0.00
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.184B 15.00
Vireo Growth (VREOF) United States $0.162B 0.00
Exagen (XGN) United States $0.151B 0.00
FitLife Brands (FTLF) United States $0.123B 15.13
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.101B 13.05
MacroGenics (MGNX) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.094B 0.00
Jushi Holdings (JUSHF) United States $0.092B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.040B 54.00
Safety Shot (SHOT) United States $0.040B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.87
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00